KRAS and colorectal carcinoma: Another interesting observation is the upregulation of the cancer stem cell marker, a cluster of Differentiation 133 (CD133), which determines the poor overall survival in colorectal cancer (CRC) and is regulated by the mutation of KRAS or BRAF [102].